Pharma News

Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, generics, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery.  US Food and Drug Administration (USFDA) upgraded Jubilant Hollisterstier's pharmaceutical sterile manufacturing facility in Spokane, Washington (USA)  to the status of Voluntary Action Indicated (VAI). This upgradation by the USFDA from Official Action Indicated (OAI) to VAI is indicative of the cGMP status at the facility since receiving the warning letter in 2013.

A new study suggests, severe restless legs syndrome (RLS) is related with subsequent increased risk of stroke. Factors which cause increased RLS severity are age, smoking, hypertension and unhealthy diet.

Glenmark Pharmaceuticals Inc., USA (Glenmark) get final approval by the United States Food & Drug Administration (FDA) for calcipotriene cream, 0.005 per cent, the therapeutic equivalent of Dovonex cream, 0.005 per cent of Leo Pharma A/S.  Glenmark strategy to start to shipping of calcipotriene cream, 0.005 per cent immediately.

A new study says, duration of antibiotic treatment for complicated abdominal infections can be cut by half and remain equally effective. and prevent development of antibiotic-resistant superbugs. The results were detailed out online in New England Journal of Medicine.

A new research claims, Autism Spectrum Disorder More Frequently Observed in Boys Than in Girls. The study was published in the journal Molecular Autism.

Autism spectrum disorder (ASD) is a condition that affects social interaction, communication, interests and behaviour. The study followed a large sample of boys and girls at high-risk for the disorder and other children at low risk beginning before 18 months of age. One in four high-risk boys were identified with the disorder at three years, compared to one in 10 high-risk girls.

Finnish researchers have developed the world's first paper-based drug test that enables a rapid analysis of whether a compound, such as morphine, is present in a given sample. Researchers from VTT Technical Research Centre of Finland used antibodies - produced by methods of molecular biology - as morphine sensing molecules to create the drug test printed on paper.

The immune system release specific antibodies when it encounters a virus. It can continue to produce those antibodies decades after an infection subsides. VirScan test detects those antibodies and uses them as a window in time to create a blueprint of nearly every virus an individual has encountered.  The test, known as VirScan, works by screening the blood for antibodies against any of the 206 species of viruses known to infect humans.Researchers at Columbia University found a DNA-based blood test which can determine a person's entire viral history. This new test can lead to early detection of hepatitis C, certain autoimmune diseases and cancers. This new innovation test only for a single suspected virus. The study appears in Science.